We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-14.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$259B
AUM Growth
-$50.1B
Cap. Flow
-$2.12B
Cap. Flow %
-0.82%
Top 10 Hldgs %
21.65%
Holding
3,641
New
264
Increased
1,460
Reduced
1,409
Closed
415

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
UNH icon
UnitedHealth
UNH
+$463M
3
ORCL icon
Oracle
ORCL
+$392M
4
ELV icon
Elevance Health
ELV
+$387M
5
PEP icon
PepsiCo
PEP
+$343M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$321M
2
BIDU icon
Baidu
BIDU
+$269M
3
NVDA icon
NVIDIA
NVDA
+$262M
4
ABBV icon
AbbVie
ABBV
+$260M
5
GM icon
General Motors
GM
+$248M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Healthcare 13.99%
3 Financials 12.35%
4 Consumer Discretionary 10.52%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORRF icon
2876
Orrstown Financial Services
ORRF
$838M
$766K ﹤0.01%
31,710
+427
+1% +$10.2K
EEM icon
2877
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$764K ﹤0.01%
19,052
TCBX icon
2878
Third Coast Bancshares
TCBX
$738M
$762K ﹤0.01%
+34,796
New +$809K
AMLX icon
2879
Amylyx Pharmaceuticals
AMLX
$2.54B
$761K ﹤0.01%
39,487
+26,257
+198% +$312K
ASTR
2880
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$759K ﹤0.01%
+38,893
New +$1.59M
MIRM icon
2881
Mirum Pharmaceuticals
MIRM
$6.14B
$756K ﹤0.01%
38,803
-36,752
-49% -$867K
NREF
2882
NexPoint Real Estate Finance
NREF
$342M
$756K ﹤0.01%
37,303
-41,956
-53% -$962K
DXLG icon
2883
Destination XL Group
DXLG
$35.4M
$751K ﹤0.01%
+221,355
New +$997K
DSKE
2884
DELISTED
Daseke, Inc. Common Stock
DSKE
$749K ﹤0.01%
117,147
+2,052
+2% +$15.7K
AVAH icon
2885
Aveanna Healthcare
AVAH
$2.07B
$748K ﹤0.01%
331,118
+117,968
+55% +$342K
NETI
2886
DELISTED
Eneti Inc.
NETI
$747K ﹤0.01%
+121,648
New +$780K
ALBO
2887
DELISTED
Albireo Pharma Inc
ALBO
$741K ﹤0.01%
37,289
-11,518
-24% -$304K
BVS icon
2888
Bioventus
BVS
$1.19B
$740K ﹤0.01%
108,550
+40,964
+61% +$418K
INVE icon
2889
Identive
INVE
$61.9M
$740K ﹤0.01%
63,981
+1,115
+2% +$14K
TNGX icon
2890
Tango Therapeutics
TNGX
$4.41B
$740K ﹤0.01%
163,334
+119,055
+269% +$721K
ULH icon
2891
Universal Logistics Holdings
ULH
$529M
$738K ﹤0.01%
27,052
+7,430
+38% +$177K
VLDR
2892
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$738K ﹤0.01%
771,961
+556,775
+259% +$962K
SRG
2893
Seritage Growth Properties
SRG
$136M
$736K ﹤0.01%
141,256
-216
-0.2% -$1.93K
MGTX icon
2894
MeiraGTx Holdings
MGTX
$1.21B
$734K ﹤0.01%
96,853
-2,355
-2% -$22.8K
FINV
2895
FinVolution Group
FINV
$1.15B
$730K ﹤0.01%
153,600
+46,600
+44% +$188K
ABSI icon
2896
Absci
ABSI
$1.51B
$728K ﹤0.01%
219,065
+61,670
+39% +$307K
PVBC
2897
DELISTED
Provident Bancorp
PVBC
$727K ﹤0.01%
46,311
-8,246
-15% -$128K
CLSK icon
2898
CleanSpark
CLSK
$3.16B
$725K ﹤0.01%
184,922
+56,926
+44% +$383K
VNET
2899
VNET Group
VNET
$2.09B
$725K ﹤0.01%
120,000
CSTE icon
2900
Caesarstone
CSTE
$79.5M
$718K ﹤0.01%
78,640
-47,319
-38% -$453K

Similar funds

Nuveen's Q2 2022 Portfolio in Review

As of Q2 2022, Nuveen held 3,641 positions worth $259B, down 16% from $309B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2022 filing shows 264 new, 1,460 increased, 1,409 reduced and 415 closed positions. Its largest new stake was Coinbase: 292,590 shares worth $13.8M. The largest sale was Cisco, an estimated $321M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2022 buy was Coinbase: 292,590 shares worth $13.8M.
  • Nuveen added most to Linde in Q2 2022, an estimated $499M increase.
  • Nuveen's biggest Q2 2022 reduction was Cisco, cutting an estimated $321M.
  • Nuveen fully exited Cerner Corp in Q2 2022, selling an estimated $135M.
  • Nuveen's ten largest holdings make up 22% of its $259B portfolio in Q2 2022.
  • Nuveen opened 264 new positions and closed 415 in Q2 2022.
  • Nuveen's portfolio value fell 16% quarter-over-quarter to $259B.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.